Table 1.
Demographic and clinical characteristics of study population.
| Variables | Overall (n = 288) n % |
Faller (n = 54) n % |
Nonfaller (n = 234) n % |
|---|---|---|---|
| Age group (year) | |||
| 60–64 | 118 (41.0) | 20 (37.0) | 98 (41.9) |
| 65–69 | 89 (30.9) | 9 (16.7) | 80 (34.2) |
| 70–74 | 49 (17.0) | 13 (24.1) | 36 (15.4) |
| >75 | 32 (11.1) | 12 (22.2) | 20 (8.5) |
| Sex | |||
| Male | 132 (45.8) | 17 (31.5) | 115 (49.1) |
| Female | 156 (54.2) | 37 (68.5) | 119 (50.9) |
| Living arrangement | |||
| Alone | 31 (10.8) | 7 (13.0) | 24 (11.0) |
| With family | 257 (89.2) | 47 (87.0) | 210 (89.7) |
| Duration of DM (years) | 10.0 ± 11.0 | 13.3 ± 11.0 | 9.0 ± 10.3 |
| Barthel's index | 98.4 ± 6.7 | 95.8 ± 11.7 | 99.0 ± 4.8 |
| Balance and gait scoring | 24.1 ± 6.5 | 20.9 ± 4.5 | 24.8 ± 6.6 |
| BMI (kg/m2) | 30.8 ± 4.9 | 31.2 ± 5.6 | 31.24 ± 95.4 |
| Hypertension | 180 (62.5) | 37 (68.5) | 144 (61.5) |
| Nephropathy | 44 (15.3) | 9 (16.7) | 35 (15.0) |
| Retinopathy | 55 (19.1) | 17 (31.5) | 38 (16.2) |
| Peripheral neuropathy | 139 (48.3) | 34 (63.0) | 105 (44.9) |
| Use of insulin | 58 (21.0) | 15 (27.8) | 43 (18.4) |
| Polypharmacy | 232 (80.6) | 46 (85.2) | 186 (79.5) |
| Hypoglycemia episode | 57 (19.8) | 16 (29.6) | 41 (17.5) |
| Orthostatic hypotension | 35 (12.2) | 13 (24.1) | 22 (9.4) |
| FBS level (mmol/L) | 6.9 ± 4.4 | 6.6 ± 3.9 | 7.4 ± 4.5 |
| HbA1C level (mmol/L) | 8.2 ± 2.4 | 7.6 ± 2.4 | 8.3 ± 2.4 |
| LDL level (mmol/L) | 3.0 ± 1.2 | 3.0 ± 1.0 | 3.1 ± 0.8 |
| Serum creatinine (mmol/L) | 115.0 ± 40.7 | 117.3 ± 34.8 | 108.0 ± 42.0 |